FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3660711000001103: Gliclazide 30mg modified-release tablets 84 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22290501000001116 Gliclazide 30mg modified-release tablets 84 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22290601000001117 Gliclazide 30mg modified-release tablets 84 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 30mg modified-release tablets 84 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Is pack of Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has active ingredient Gliclazide false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has VMP Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has VMP Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets 84 tablet Has VMP Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Diamicron 30mg MR tablets (Servier Laboratories Limited) 84 tablet 3 x 28 tablets Is a True Gliclazide 30mg modified-release tablets 84 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start